Evidence map›Paper›PMID 31581508›Full record

ArticleVaccines2019

Seroepidemiology of Measles, Mumps and Rubella on Bonaire, St. Eustatius and Saba: The First Population-Based Serosurveillance Study in Caribbean Netherlands.

Regnerus A Vos, Liesbeth Mollema, Rob van Binnendijk, Irene K Veldhuijzen, Gaby Smits, Alcira V A Janga-Jansen, Sharda Baboe-Kalpoe, Koen Hulshof, Fiona R M van der Klis, Hester E de Melker

Abstract read
In one paragraph

Article in Vaccines, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Multiplex Bead Assay for the Serological Surveillance of Measles and Rubella.Methods in molecular biology (Clifton, N.J.) · 2024
    Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Regnerus A VosCentre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Antonie van Leeuwenhoeklaan 9, 3720 MA Bilthoven, The Netherlands. eric.vos.02@rivm.nl.
Liesbeth MollemaCentre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Antonie van Leeuwenhoeklaan 9, 3720 MA Bilthoven, The Netherlands. liesbeth.mollema@rivm.nl.
Rob van BinnendijkCentre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Antonie van Leeuwenhoeklaan 9, 3720 MA Bilthoven, The Netherlands. rob.van.binnendijk@rivm.nl.
Irene K VeldhuijzenCentre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Antonie van Leeuwenhoeklaan 9, 3720 MA Bilthoven, The Netherlands. irene.veldhuijzen@rivm.nl.
Gaby SmitsCentre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Antonie van Leeuwenhoeklaan 9, 3720 MA Bilthoven, The Netherlands. gaby.smits@rivm.nl.
Alcira V A Janga-JansenDepartment of Public Health, Public Entity Bonaire, Kaya Neerlandia 41, Kralendijk Bonaire, Caribbean Netherlands, The Netherlands. alcira.jansen@bonairegov.com.
Sharda Baboe-KalpoeDepartment of Public Health, Public Entity St. Eustatius, Cottageroad z/n, Oranjestad, St. Eustatius, Caribbean Netherlands, The Netherlands. s.baboe-kalpoe@statiagov.com.
Koen HulshofDepartment of Public Health, Public Entity Saba, The Bottom, Saba, Caribbean Netherlands, The Netherlands. koen.hulshof@sabagov.com.
Fiona R M van der KlisCentre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Antonie van Leeuwenhoeklaan 9, 3720 MA Bilthoven, The Netherlands. fiona.van.der.klis@rivm.nl.
Hester E de MelkerCentre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Antonie van Leeuwenhoeklaan 9, 3720 MA Bilthoven, The Netherlands. hester.de.melker@rivm.nl.

Funding

Ministerie van Volksgezondheid, Welzijn en Sport N.A.
6 · The paper itself

Abstract

The National Immunization Program (NIP) on Bonaire, St. Eustatius and Saba (i.e., Caribbean Netherlands (CN)) includes the measles-mumps-rubella (MMR) vaccine since 1988/89. Seroepidemiological data is an important tool to evaluate the NIP, hence a cross-sectional representative population-based serosurveillance study was conducted for the first time in CN in mid-2017. Participants (

Indexed as

BonaireCaribbean NetherlandsmeaslesMMR vaccinationmumpsrubellaSabaseroepidemiologySt. Eustatius

Identifiers

PMID31581508
PMCPMC6963433

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.